5.29
price up icon4.13%   0.21
after-market 시간 외 거래: 5.61 0.32 +6.05%
loading
전일 마감가:
$5.08
열려 있는:
$5.1
하루 거래량:
544.91K
Relative Volume:
2.66
시가총액:
$288.71M
수익:
$21.05M
순이익/손실:
$-89.22M
주가수익비율:
-1.8304
EPS:
-2.89
순현금흐름:
$-64.50M
1주 성능:
+11.37%
1개월 성능:
-3.99%
6개월 성능:
-38.20%
1년 성능:
+29.66%
1일 변동 폭
Value
$5.065
$5.98
1주일 범위
Value
$4.53
$5.98
52주 변동 폭
Value
$3.73
$9.69

Tscan Therapeutics Inc Stock (TCRX) Company Profile

Name
명칭
Tscan Therapeutics Inc
Name
전화
857-399-9500
Name
주소
880 WINTER STREET, WALTHAM
Name
직원
188
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
TCRX's Discussions on Twitter

Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-16 개시 BTIG Research Buy
2024-05-13 개시 Needham Buy
2023-06-22 개시 Wedbush Outperform

Tscan Therapeutics Inc 주식(TCRX)의 최신 뉴스

pulisher
09:17 AM

TScan Therapeutics Announces Upcoming Oral Presentation of - GlobeNewswire

09:17 AM
pulisher
09:15 AM

TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition - StockTitan

09:15 AM
pulisher
04:52 AM

TScan Therapeutics' SWOT analysis: innovative therapy stock faces pivotal year - Investing.com India

04:52 AM
pulisher
Nov 04, 2024

Waltham cancer biotech adds to real estate footprint - The Business Journals

Nov 04, 2024
pulisher
Nov 04, 2024

TScan Therapeutics (NASDAQ:TCRX) Enters Second Amendment for Lease Agreement to Expand Operations at Winter Street FacilityOn October 28, 2024, TScan Therapeutics, Inc. finalized a second amendment to its lease agreement with PPF OFF 828-83 - Defense World

Nov 04, 2024
pulisher
Oct 26, 2024

Head to Head Review: ProKidney (NASDAQ:PROK) vs. TScan Therapeutics (NASDAQ:TCRX) - Defense World

Oct 26, 2024
pulisher
Oct 21, 2024

The Manufacturers Life Insurance Company Invests $90,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Oct 21, 2024
pulisher
Oct 18, 2024

Where are the Opportunities in (TCRX) - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 15, 2024

BTIG Initiates Coverage of TScan Therapeutics (TCRX) with Buy Recommendation - MSN

Oct 15, 2024
pulisher
Oct 08, 2024

Bank of Montreal Can Acquires Shares of 120,454 TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Bank of Montreal Can Invests $749,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Oct 08, 2024
pulisher
Oct 06, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Stock Position Lifted by Marshall Wace LLP - MarketBeat

Oct 06, 2024
pulisher
Oct 05, 2024

American Century Companies Inc. Increases Position in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

TCRXTScan Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 04, 2024
pulisher
Oct 04, 2024

TScan Therapeutics Announces Upcoming Presentations at the - GlobeNewswire

Oct 04, 2024
pulisher
Oct 04, 2024

TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting - StockTitan

Oct 04, 2024
pulisher
Oct 04, 2024

Reviewing TScan Therapeutics (NASDAQ:TCRX) and Sorrento Therapeutics (OTCMKTS:SRNEQ) - Defense World

Oct 04, 2024
pulisher
Oct 01, 2024

Tscan Therapeutics Inc [TCRX] Stock bought by Insider Klencke Barbara for $26450.0 - Knox Daily

Oct 01, 2024
pulisher
Oct 01, 2024

Was there any good news for Tscan Therapeutics Inc (TCRX) stock in the last session? - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

Market Momentum Report: Tscan Therapeutics Inc (TCRX)’s Negative Close at 4.98 - The Dwinnex

Oct 01, 2024
pulisher
Sep 30, 2024

TScan Therapeutics's SWOT analysis: biotech stock faces pivotal year - Investing.com

Sep 30, 2024
pulisher
Sep 28, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Sees Significant Growth in Short Interest - MarketBeat

Sep 28, 2024
pulisher
Sep 25, 2024

92,832 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Bought by Troluce Capital Advisors LLC - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Director Barbara Klencke Acquires 5,000 Shares - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

TScan therapeutics director buys $26,450 in company stock By Investing.com - Investing.com South Africa

Sep 24, 2024
pulisher
Sep 24, 2024

TScan therapeutics director buys $26,450 in company stock - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

940,831 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Purchased by Great Point Partners LLC - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Great Point Partners LLC Makes New Investment in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Bank of New York Mellon Corp Purchases New Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) - MarketBeat

Sep 23, 2024
pulisher
Sep 19, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Shares Sold by Marathon Trading Investment Management LLC - Defense World

Sep 19, 2024
pulisher
Sep 13, 2024

When the Price of (TCRX) Talks, People Listen - Stock Traders Daily

Sep 13, 2024
pulisher
Sep 05, 2024

TCRX Stock Sees Surge of Approximately 1.08% in Last Five Days - Knox Daily

Sep 05, 2024
pulisher
Sep 02, 2024

Can Tscan Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Sep 02, 2024
pulisher
Sep 02, 2024

Its Stock Has Paid Off Big Time For Tscan Therapeutics Inc - SETE News

Sep 02, 2024
pulisher
Aug 29, 2024

TScan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Aug 29, 2024
pulisher
Aug 29, 2024

TScan Therapeutics Director Acquires 18% More Stock - Simply Wall St

Aug 29, 2024
pulisher
Aug 28, 2024

How To Trade (TCRX) - Stock Traders Daily

Aug 28, 2024
pulisher
Aug 28, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Insider Zoran Zdraveski Sells 164,686 Shares of Stock - Defense World

Aug 28, 2024
pulisher
Aug 28, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) Director Acquires $27,650.00 in Stock - MarketBeat

Aug 28, 2024
pulisher
Aug 28, 2024

TScan Therapeutics director buys $56,100 in company shares - Investing.com India

Aug 28, 2024
pulisher
Aug 27, 2024

TScan therapeutics executive sells over $950k in company stock By Investing.com - Investing.com Canada

Aug 27, 2024
pulisher
Aug 26, 2024

TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology (TCRX) - Seeking Alpha

Aug 26, 2024
pulisher
Aug 16, 2024

TScan Therapeutics, Inc. (NASDAQ:TCRX) to Post FY2024 Earnings of ($1.07) Per Share, Lifesci Capital Forecasts - MarketBeat

Aug 16, 2024
pulisher
Aug 15, 2024

FY2024 Earnings Estimate for TScan Therapeutics, Inc. Issued By Lifesci Capital (NASDAQ:TCRX) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

FY2024 EPS Estimates for TScan Therapeutics, Inc. Decreased by Analyst (NASDAQ:TCRX) - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

TScan Therapeutics, Inc. Forecasted to Earn Q3 2024 Earnings of ($0.31) Per Share (NASDAQ:TCRX) - Defense World

Aug 15, 2024
pulisher
Aug 14, 2024

TScan Therapeutics (NASDAQ:TCRX) Issues Quarterly Earnings Results - MarketBeat

Aug 14, 2024
pulisher
Aug 14, 2024

TScan Therapeutics (NASDAQ:TCRX) Receives Buy Rating from HC Wainwright - Defense World

Aug 14, 2024
pulisher
Aug 14, 2024

TScan Therapeutics (NASDAQ:TCRX) Rating Reiterated by Needham & Company LLC - Defense World

Aug 14, 2024
pulisher
Aug 13, 2024

TScan Therapeutics (NASDAQ:TCRX) Receives “Outperform” Rating from Wedbush - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts - Benzinga

Aug 13, 2024

Tscan Therapeutics Inc (TCRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):